Short Summary
The PTAB denied Apple's IPR against Ferid Allani's patent, finding that the petitioner failed to demonstrate a reasonable likelihood of prevailing on any challenged claim.
Detailed Summary
In this Institution Decision, the Patent Trial and Appeal Board denied Apple Inc.'s Petition for Inter Partes Review (IPR) against Ferid Allani regarding Patent No. 8,271,877 B2. The Board determined that Petitioner failed to meet the 'reasonable likelihood' standard under 35 U.S.C. § 314(a). A key point of analysis involved construing the term "beforehand locally stored," which was ultimately construed as requiring storage prior to the start of a preliminary search. Based on this construction, the Board found that the primary prior art reference, Rossmann, did not disclose this limitation.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Apple Inc. vs Allani, Ferid is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
AZURITY PHARMACEUTICALS, INC.vsHelsinn Healthcare S.A.
Azurity has filed an IPR petition seeking cancellation of all 23 claims of Helsinn’s anti‑emetic patent (US 10,828,297) on the ground that the claims are obvious over standard chemotherapy anti‑emetic regimens. The petition argues the examiner’s reliance on alleged unexpected synergy is unsupported.
Apple Inc.vsVaria Holdings LLC
Apple has filed an IPR petition challenging Varia Holdings’ ’947 RFID patent, asserting that all 32 claims are obvious over prior‑art Bluetooth/RFID references. The petition seeks institution and argues discretionary denial is unwarranted.
Apple Inc.vsTelcom Ventures LLC
Apple has filed an IPR petition seeking cancellation of all 19 claims of Telcom Ventures’ U.S. Patent 10,219,199, alleging obviousness over a suite of prior‑art references covering NFC‑based mobile payments.
ClearCorrect Operating, LLC et al.vsAlign Technology, Inc.
ClearCorrect challenges Align Technology’s dental aligner patent in an IPR, and Align seeks to deny the Patent Owner’s Director Review request. The response argues the new RPI theory and trial‑date evidence are improper, and that the Board’s institution decision was correct.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
The USPTO initiated a sua sponte Director Review of an IPR involving aesthetic device patents, staying the proceeding after an ITC finding of commercial success and non‑invalidity.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.